Pharmabiz

WuXi Biologics’ MFG8 drug substance facility secures US FDA Pre-License Inspection approval

WuXi Biologics’ MFG8 drug substance facility secures US FDA Pre-License Inspection approval: Hebei, China Saturday, July 11, 2026, 17:00 Hrs [IST] WuXi Biologics, a leading glob ...
Pharmabiz

Virax Biolabs enters exclusive multi-country commercial supply agreement with Fosun Diagnostics

Virax Biolabs enters exclusive multi-country commercial supply agreement with Fosun Diagnostics: London Saturday, July 11, 2026, 11:00 Hrs [IST] Virax Biolabs Group Limited, a bio ...
Pharmabiz

CHOP secures five-year, up to $38.9 million ARPA-H award to advance personalized gene editing therapies

CHOP secures five-year, up to $38.9 million ARPA-H award to advance personalized gene editing therapies: Philadelphia, Pennsylvania Saturday, July 11, 2026, 14:00 Hrs [IST] Childr ...
Pharmabiz

Blue Earth Therapeutics and University College London initiate phase 1 trial evaluating Actinium (225Ac) rhPSMA-10.1 injection in mCRPC

Blue Earth Therapeutics and University College London initiate phase 1 trial evaluating Actinium (225Ac) rhPSMA-10.1 injection in mCRPC: Oxford, UK Saturday, July 11, 2026, 16:00 ...
Pharmabiz

OKYO Pharma announces positive feedback from US FDA Type D Meeting and accelerates urcosimod into global phase 3 trial for NCP

OKYO Pharma announces positive feedback from US FDA Type D Meeting and accelerates urcosimod into global phase 3 trial for NCP: London Saturday, July 11, 2026, 18:00 Hrs [IST] OKY ...
Pharmabiz

NPPA fixes retail price of 39 new drugs based on 47 applications

NPPA fixes retail price of 39 new drugs based on 47 applications: Gireesh Babu, New Delhi Saturday, July 11, 2026, 08:00 Hrs ...
Pharmabiz

Cell Therapies supports Australian phase I/Ib clinical trial of A-SEEDS’ ACS2015 CAR-T therapy for solid tumours

Cell Therapies supports Australian phase I/Ib clinical trial of A-SEEDS’ ACS2015 CAR-T therapy for solid tumours: Australia Saturday, July 11, 2026, 13:00 Hrs [IST] Cell Therapi ...
Pharmabiz

Intas Pharma’s US specialty division, Accord BioPharma receives US FDA approval for Ennumo, a biosimilar to Neulasta

Intas Pharma’s US specialty division, Accord BioPharma receives US FDA approval for Ennumo, a biosimilar to Neulasta: Raleigh, North Carolina Saturday, July 11, 2026, 12:00 Hrs ...
Pharmabiz

CDA issues reimbursement recommendation for Empaveli to treat C3 glomerulopathy and primary IC-MPGN

CDA issues reimbursement recommendation for Empaveli to treat C3 glomerulopathy and primary IC-MPGN: Waltham, Massachusetts Saturday, July 11, 2026, 15:00 Hrs [IST] Swedish Orphan ...
Pharmabiz

Daman to host 4th national congress of drugs control officers to strengthen India's public health regulations

Daman to host 4th national congress of drugs control officers to strengthen India's public health regulations: Our Bureau, Chennai Friday, July 10, 2026, 13:30 Hrs [IST] The 4th A ...
Pharmabiz

Prataprao Jadhav calls for medicinal plant forests in Delhi to strengthen Ayush and biodiversity conservation

Prataprao Jadhav calls for medicinal plant forests in Delhi to strengthen Ayush and biodiversity conservation: Our Bureau, Mumbai Saturday, July 11, 2026, 11:15 Hrs [IST] Union mi ...
Pharmabiz

Bayer secures 3.0 billion euros to improve capital structure

Bayer has secured 3.0 billion euros in equity capital to improve its capital structure. The company signed a respective agreement with the global asset management firm Apollo on Friday. Under the ...